Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 11,486 shares at $25.08 ($288K) on 2021-09-10, disclosed to the SEC on 2021-09-14.
Open-market sale of $288k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.08 | 2,942 | $74K | 25.6% |
| 2 | $25.08 | 2,942 | $74K | 25.6% |
| 3 | $25.02 | 2,801 | $70K | 24.4% |
| 4 | $25.02 | 2,801 | $70K | 24.4% |
| Total | $25.05 avg | 11,486 | $288K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |